Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Liabilities: 2020-2024

Historic Total Liabilities for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $431.0 million.

  • Maravai Lifesciences Holdings' Total Liabilities fell 37.30% to $417.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $417.3 million, marking a year-over-year decrease of 37.30%. This contributed to the annual value of $431.0 million for FY2024, which is 38.21% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Total Liabilities of $431.0 million as of FY2024, which was down 38.21% from $697.6 million recorded in FY2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Total Liabilities peaked at $1.4 billion during FY2022, and registered a low of $431.0 million during FY2024.
  • For the 3-year period, Maravai Lifesciences Holdings' Total Liabilities averaged around $835.2 million, with its median value being $697.6 million (2023).
  • Its Total Liabilities has fluctuated over the past 5 years, first climbed by 23.03% in 2021, then slumped by 49.34% in 2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Total Liabilities (Yearly) stood at $1.1 billion in 2020, then climbed by 23.03% to $1.4 billion in 2021, then rose by 0.30% to $1.4 billion in 2022, then tumbled by 49.34% to $697.6 million in 2023, then plummeted by 38.21% to $431.0 million in 2024.